EP Patent

EP1878447A2 — Medium for contrast enhancement or convenience for ultrasonic, endoscopic and other medical examinations

Assigned to Ultrast LLC · Expires 2008-01-16 · 18y expired

What this patent protects

The present invention relates to a particularly convenient medium for providing contrast enhancement and/or distension of the subject body or organ cavity during imaging, radiographic, visualization, or other similar medical examinations, including ultrasound, endoscopic examinat…

USPTO Abstract

The present invention relates to a particularly convenient medium for providing contrast enhancement and/or distension of the subject body or organ cavity during imaging, radiographic, visualization, or other similar medical examinations, including ultrasound, endoscopic examinations, MRI, x-ray, hystero-salpingograms, CT scans, and similar procedures. The present invention provides the contrast enhancement and/or distends the body or organ cavity without constant leakage of the medium or the resulting need to constantly or repeatedly infuse additional medium. The medium is designed to have sufficient viscosity or consistence initially -- whether as a solid, semi-solid, gel, viscous fluid, or otherwise -- to remain in the body or organ cavity for a time generally sufficient to complete the procedure, and then to facilitate easy removal or expulsion from the cavity, preferably by liquefying or losing viscosity. For imaging and radiographic examinations, the medium may provide enhanced contrast as well as the distension of the cavity. For visualization examinations, the medium typically would be optically transparent but provide the convenient reliable distension. The phase or viscosity change may be triggered by a variety factors, such as the passage of time, a change in temperature or pH, the addition of another substance, or any other trigger that liquefies or otherwise facilitates easy removal or expulsion of the composition from the cavity.

Drugs covered by this patent

Patent Metadata

Patent number
EP1878447A2
Jurisdiction
EP
Classification
Expires
2008-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Ultrast LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.